249 related articles for article (PubMed ID: 35399330)
1. miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.
Yang L; Liu S; Yang L; Xu B; Wang M; Kong X; Song Z
Oncol Lett; 2022 May; 23(5):162. PubMed ID: 35399330
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
Guo R; Hu T; Liu Y; He Y; Cao Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
[TBL] [Abstract][Full Text] [Related]
3. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
4. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
6. miR-30e-5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin.
Zhang Z; Qin H; Jiang B; Chen W; Cao W; Zhao X; Yuan H; Qi W; Zhuo D; Guo H
J Cell Biochem; 2019 Sep; 120(9):15924-15932. PubMed ID: 31069875
[TBL] [Abstract][Full Text] [Related]
7. mir-21-5p inhibits the progression of human chondrosarcoma by regulating CCR7/STAT3/NF-κB pathway.
Li G; Yang Y; Xu S; He M; Zhang Z
Connect Tissue Res; 2021 May; 62(3):313-324. PubMed ID: 31813289
[No Abstract] [Full Text] [Related]
8. Sevoflurane Suppresses the Migration, Invasion, and Epithelial-Mesenchymal Transition of Breast Cancer Cells Through the miR-139-5p/ARF6 Axis.
Wu T; Sun L; Wang C; Yu P; Cheng L; Chen Y
J Surg Res; 2021 Feb; 258():314-323. PubMed ID: 33317757
[TBL] [Abstract][Full Text] [Related]
9. MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1.
Li Y; Zeng Q; Qiu J; Pang T; Ye F; Huang L; Zhang X
J Breast Cancer; 2020 Aug; 23(4):355-372. PubMed ID: 32908787
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
Zhao C; Ling X; Li X; Hou X; Zhao D
Breast Cancer; 2019 Nov; 26(6):817-825. PubMed ID: 31243644
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
12. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
Li W; Zhai L; Zhao C; Lv S
Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195-5p suppresses the proliferation, migration, invasion and epithelial-mesenchymal transition of laryngeal cancer cells
Zhou M; Wang Y; Zhang C; Qi M; Yao M; Sun L; Xu X
Exp Ther Med; 2021 Oct; 22(4):1078. PubMed ID: 34447471
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of miR-150-5p reduces hypoxia-induced autophagy and epithelial-mesenchymal transition of endometriotic cells via regulating the PDCD4/NF-κB signaling pathway.
Chen ML; Fan L; Huang GR; Sun ZF
Cytokine; 2023 Feb; 162():156086. PubMed ID: 36427469
[TBL] [Abstract][Full Text] [Related]
15. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
Xin H; Wang C; Liu Z
BMC Cancer; 2019 Jan; 19(1):30. PubMed ID: 30621631
[TBL] [Abstract][Full Text] [Related]
16. Clinical roles of miR-136-5p and its target metadherin in thyroid carcinoma.
Gao RZ; Que Q; Lin P; Pang YY; Wu HY; Li XJ; Chen G; He Y; Yang H
Am J Transl Res; 2019; 11(11):6754-6774. PubMed ID: 31814886
[TBL] [Abstract][Full Text] [Related]
17. MiR-524-5p Suppresses Migration, Invasion, and EMT Progression in Breast Cancer Cells Through Targeting
Jin T; Zhang Y; Zhang T
Cancer Biother Radiopharm; 2020 Dec; 35(10):789-801. PubMed ID: 32298609
[No Abstract] [Full Text] [Related]
18. MIR-518a-5p Targets ZEB2 to Suppress the Migration and Invasion of Breast-cancer Cells.
Wang L; Guo Z; Zhang S; Zhang X; Sang M; Liu Y; Shan B
Altern Ther Health Med; 2023 Jan; 29(1):137-143. PubMed ID: 35986741
[TBL] [Abstract][Full Text] [Related]
19. MiR-135-5p inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by targeting SMAD3 in breast cancer.
Yang W; Feng W; Wu F; Gao Y; Sun Q; Hu N; Lu W; Zhou J
J Cancer; 2020; 11(21):6402-6412. PubMed ID: 33033523
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
